N,N-Dimethylethanolamine?(DMEA)


  • Product Name
  • CasNo
  • MF
  • MW
  • Content
  • Appearance
  • Packing
  • Apply
  • N,N-Dimethylethanolamine?(DMEA)
  • 108-01-0
  • C4H11NO
  • 89.1374
  • clear to pale yellow liquid
Inquiry

Factory Sells Best Quality N,N-Dimethylethanolamine?(DMEA) 108-01-0 with steady supply

  • Molecular Formula:C4H11NO
  • Molecular Weight:89.1374
  • Appearance/Colour:clear to pale yellow liquid 
  • Vapor Pressure:100 mm Hg ( 55 °C) 
  • Melting Point:-70 °C 
  • Refractive Index:n20/D 1.4294(lit.)  
  • Boiling Point:135 °C at 760 mmHg 
  • PKA:pK1:9.26(+1) (25°C) 
  • Flash Point:40.6 °C 
  • PSA:23.47000 
  • Density:0.897 g/cm3 
  • LogP:-0.45970 

N,N-Dimethylethanolamine(Cas 108-01-0) Usage

Preparation

The synthesis of 2-Dimethylaminoethanol by the ethylene oxide method is obtained by the ammonification of dimethylamine with ethylene oxide, which is distilled, refined and dehydrated.

Production Methods

Synthesis of dimethylaminoethanol can be accomplished from equimolar amounts of ethylene oxide and dimethylamine (HSDB 1988).

Air & Water Reactions

Flammable. Partially soluble in water and less dense than water.

Reactivity Profile

DIMETHYLAMINOETHANOL is an aminoalcohol. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides. N,N-Dimethylethanolamine may react vigorously with oxidizing materials.

Health Hazard

Dimethylaminoethanol is classified as a mild skin irritant and a severe eye irritant (HSDB 1988). Doses as high as 1200 mg daily produce no serious side effects and a single dose of 2500 mg taken in a suicide attempt had no adverse effects (Gosselin et al 1976). Inhalation of the vapor or mist can cause irritation to the upper respiratory tract. Asthmatic symptoms have been reported. Extremely irritating; may cause permanent eye injury. Corrosive; will cause severe skin damage with burns and blistering. Ingestion may cause damage to the mucous membranes and gastrointestinal tract. No reports were found in the literature regarding carcinogenic or mutagenic potential.

Flammability and Explosibility

Flammable

Safety Profile

Moderately toxic by ingestion, inhalation, skin contact, intraperitoneal, and subcutaneous routes. A skin and severe eye irritant. Used medically as a central nervous system stimulant. Flammable liquid when exposed to heat or flame; can react vigorously with oxidzing materials. Ignites spontaneously in contact with cellulose nitrate of high surface area. To fight fire, use alcohol foam, foam, CO2, dry chemical. When heated to decomposition it emits toxic fumes of NOx

Metabolism

When administered orally, dimethylaminoethanol acetamidobenzoate (the therapeutic salt formulation) has been shown to cross the blood-brain barrier (HSDB 1988). Two other studies have examined the pharmacokinetics of dimethylaminoethanol in rats (Dormand et al 1975) and healthy adults (Bismut et al 1986). It has been postulated that dimethylaminoethanol undergoes endogenous methylation (LaDu et al 1971). After intravenous treatment of mice with [14C]-labeled dimethylaminoethanol in the brain, dimethylaminoethanol yielded phosphoryldimethylaminoethanol and phosphatidyldimethylaminoethanol. Acid-soluble and lipid cholines derived from dimethylaminoethanol also were found in brain (Miyazaki et al 1976). While examining the pharmacokinetics of the maleate acid of [14C]-dimethylaminoethanol in rats, Dormand et al (1975) observed that dimethylaminoethanol was metabolized in the phospholipid cycle and produced metabolites such as phosphoryldimethylaminoethanolamine, and glycerophosphatidylcholine. In kainic-acid lesioned rats, dimethylaminoethanol was converted to a substance which cross-reacted in the radioenzymatic assay for acetylcholine (London et al 1978). Ansell and Spanner (1979) demonstrated that [14C]-dimethylaminoethanol rapidly disappeared from brain; after 0.5, 1, and 7 h, only 30, 27, and 16% of the administered radioactivity, respectively, remained in the brain after intracerebral injection. They also showed that brain levels of phosphodimethylaminoethanol increased to a maximum at 1-2 h and decreased afterwards, whereas concentrations of phosphatidylethanolamine increased continuously throughout the 7 h observation period. This study further found that after i.p. injections of labeled dimethylaminoethanol, the brain content of phosphatidylethanolamine increased through the 7 h period and the levels were 10-40 fold higher than those of phosphodimethylaminoethanol.

Purification Methods

Dry the amine with anhydrous K2CO3 or KOH, and fractionally distil it. [Beilstein 4 IV 1424.]

Definition

ChEBI: N,N-dimethylethanolamine is a tertiary amine that is ethanolamine having two N-methyl substituents. It has a role as a curing agent and a radical scavenger. It is a tertiary amine and a member of ethanolamines.

General Description

A clear colorless liquid with a fishlike odor. Flash point 105°F. Less dense than water. Vapors heavier than air. Toxic oxides of nitrogen produced during combustion. Used to make other chemicals.

Industrial uses

Dimethylaminoethanol is used as a chemical intermediate for antihistamines and local anesthetics; as a catalyst for curing epoxy resins and polyurethanes; and as a pH control agent for boiler water treatment. However, dimethylaminoethanol in the salt form, (i.e. dimethylaminoethanol acetamidobenzoate) is primarily utilized therapeutically as an antidepressant (HSDB 1988).

InChI:InChI=1/C4H11NO/c1-5(2)3-4-6/h6H,3-4H2,1-2H3

108-01-0 Relevant articles

-

Martell et al.

, p. 3471 (1975)

-

Radioiodinated phenoxyacetic acid derivatives as potential brain imaging agents. II. Structure-biodistribution relationship

Ohmomo,Okuyama,Magata,Ueno,Tanaka,Yokoyama

, p. 2282 - 2286 (1989)

-

A solvent-free and formalin-free Eschweiler-Clarke methylation for amines

Rosenau, Thomas,Potthast, Antje,Roehrling, Juergen,Hofinger, Andreas,Sixta, Herbert,Kosma, Paul

, p. 457 - 466 (2002)

Primary and secondary amines are N-methy...

pH-Dependent degradation and stabilization of meclofenoxate hydrochloride by human serum albumin

Ohta,Yotsuyanagi,Ikeda

, p. 2585 - 2590 (1986)

-

Development and scale-up of an aqueous ethanolamine scrubber for methyl bromide removal

Hettenbach, Kevin,Am Ende, David J.,Leeman, Kyle,Dias, Eric,Kasthurikrishnan, Narasimhan,Brenek, Steven J.,Ahlijanian, Paul

, p. 407 - 415 (2002)

A scrubber system was developed specific...

Syntheses of 1,2-di-O -palmitoyl-sn -glycero-3-phosphocholine (DPPC) and analogs with 13C- and 2H-labeled choline head groups

Lin, Sonyuan,Duclos Jr., Richard I.,Makriyannis, Alexandros

, p. 171 - 181 (1997)

The syntheses of four head group labeled...

-

Ruzicka,Dalma,Scott

, p. 63,67 Anm. 2, 74 (1941)

-

Kinetics of hydroxyethylation of dimethylamine

Danov,Kolesnikov,Efremov,Mezhenin

, p. 427 - 429 (2004)

The kinetics of hydroxyethylation of dim...

Preparation method N-N -dimethyl monoethanolamine

-

Paragraph 0062-0063, (2021/10/05)

The invention provides N-N - dimethyl mo...

PROCESS FOR PREPARING N-SUBSTITUTED ALKANOLAMINES AND/OR N-SUBSTITUTED DIAMINES FROM GLYCOLALDEHYDE

-

Page/Page column 9, (2021/06/22)

A process for preparing a N-substituted ...

RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

-

Paragraph 00230; 00409; 00657, (2020/07/05)

Provided herein are a RET inhibitor, a p...

General and Phosphine-Free Cobalt-Catalyzed Hydrogenation of Esters to Alcohols

Shao, Zhihui,Zhong, Rui,Ferraccioli, Raffaella,Li, Yibiao,Liu, Qiang

supporting information, p. 1125 - 1130 (2019/10/22)

Catalytic hydrogenation of esters is ess...

108-01-0 Process route

Cyclozil chloromethacryloyloxymethylate
74240-38-3

Cyclozil chloromethacryloyloxymethylate

formaldehyd
50-00-0,30525-89-4,61233-19-0

formaldehyd

2-(N,N-dimethylamino)ethanol
108-01-0

2-(N,N-dimethylamino)ethanol

poly(methacrylic acid)
79-41-4,25087-26-7,50867-57-7

poly(methacrylic acid)

2-cyclopentyl-2-hydroxy-2-phenylacetic acid
427-49-6

2-cyclopentyl-2-hydroxy-2-phenylacetic acid

Conditions
Conditions Yield
With potassium chloride; In methanol; at 24.9 ℃; Rate constant; Kinetics; Mechanism; different pH values from 298-323 K, different ion strength of KCl solution;
1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

(2-hydroxy-ethyl)-methoxy-dimethyl-ammonium; hydroxide

(2-hydroxy-ethyl)-methoxy-dimethyl-ammonium; hydroxide

formaldehyd
50-00-0,30525-89-4,61233-19-0

formaldehyd

2-(N,N-dimethylamino)ethanol
108-01-0

2-(N,N-dimethylamino)ethanol

Conditions
Conditions Yield

108-01-0 Upstream products

  • 75-21-8
    75-21-8

    oxirane

  • 124-40-3
    124-40-3

    dimethyl amine

  • 62-49-7
    62-49-7

    choline

  • 116714-27-3
    116714-27-3

    N-methoxycarbonyl-N-methyl-glycine

108-01-0 Downstream products

  • 1704-62-7
    1704-62-7

    1-O-Dimethylaminoethyl-ethylenglykol

  • 109-83-1
    109-83-1

    (2-hydroxyethyl)(methyl)amine

  • 50-00-0
    50-00-0

    formaldehyd

  • 10549-59-4
    10549-59-4

    DMAE succinate

*Product Name:
*Email:
*Description:
*Code:
Contact Now